Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Pharmacogenetics|January 25, 2003
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansChin B Eap, Etienne Lessard, Pierre Baumann, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Therapeutic Drug Monitoring|September 26, 2003
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopramYves Le Bloc'h, Brigitte Woggon, Hansjörg Weissenrieder, et al.
Case Reports in Psychiatry|September 1, 2012
Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophreniaAleksandar Chanachev, Nicolas Ansermot, Séverine Crettol Wavre, et al.
Brain and Behavior|August 15, 2018
The effect of a single dose of escitalopram on sensorimotor networksChristian Weisstanner, Georg Kägi, Werner Krammer, et al.
Therapeutic Drug Monitoring|July 22, 2008
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic responseMarianne Gex-Fabry, Chin B Eap, Beatrice Oneda, et al.
Basic & Clinical Pharmacology & Toxicology|March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric populationAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Pharmacopsychiatry|April 17, 2025
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson's Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysisNazar Kuzo, Marianna Piras, Ulrich C Lutz, et al.
Psychopharmacology|July 1, 2005
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
Pharmacogenetics|April 15, 2004
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter geneChin B Eap, Jacques Fellay, Thierry Buclin, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Pharmacogenetics|January 25, 2003
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansChin B Eap, Etienne Lessard, Pierre Baumann, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Therapeutic Drug Monitoring|September 26, 2003
Routine therapeutic drug monitoring in patients treated with 10-360 mg/day citalopramYves Le Bloc'h, Brigitte Woggon, Hansjörg Weissenrieder, et al.
Case Reports in Psychiatry|September 1, 2012
Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophreniaAleksandar Chanachev, Nicolas Ansermot, Séverine Crettol Wavre, et al.
Brain and Behavior|August 15, 2018
The effect of a single dose of escitalopram on sensorimotor networksChristian Weisstanner, Georg Kägi, Werner Krammer, et al.
Therapeutic Drug Monitoring|July 22, 2008
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic responseMarianne Gex-Fabry, Chin B Eap, Beatrice Oneda, et al.
Basic & Clinical Pharmacology & Toxicology|March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric populationAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Pharmacopsychiatry|April 17, 2025
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson's Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysisNazar Kuzo, Marianna Piras, Ulrich C Lutz, et al.
Psychopharmacology|July 1, 2005
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
Pharmacogenetics|April 15, 2004
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter geneChin B Eap, Jacques Fellay, Thierry Buclin, et al.
Pageof 18